XP8-31100-77927 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-11-05
Dose 1 — Pfizer-BioNTech
2021-11-26
Dose 2 — Pfizer-BioNTech
2021-11-27
Registered in v-safe
2021-11-27
Health check-in — days 1–6 daily, dose 2, dependent
Feeling: Good · Rash, not including the immediate area around the injection site

Adult check-in
2021-11-29
Health check-in — days 1–6 daily, dose 2, dependent
Feeling: Good · None

Adult check-in
2021-11-30
Health check-in — days 1–6 daily, dose 2, dependent
Feeling: Good · None

Adult check-in
2021-12-02
Health check-in — days 1–6 daily, dose 2, dependent
Feeling: Good · None

Adult check-in
2021-12-03
Survey response — day 7, dose 2, dependent
MedDRA: Eczema, Pre-existing disease — Feeling: Good · Rash, not including the immediate area around the injection site · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Eczema flare

MedDRA releases: 2024-11 · check-in free text available
2021-12-03
Report sent to call center — day 7, dose 2, dependent
Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2021-12-06
Call 1 — Could Not Reach Participant
2021-12-08
Call successful
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
2021-12-09
Call 2 — Could Not Reach Participant
2021-12-24
Survey response — day 28, dose 2, dependent
MedDRA: Nasopharyngitis — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Cold

MedDRA releases: 2024-11 · check-in free text available
2021-12-24
Report sent to call center — day 28, dose 2, dependent
Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2021-12-27
Call successful
Does not wish to fill out VAERS report
2022-01-07
Health check-in — day 42, dose 2, dependent
Feeling: Good

Adult check-in
2022-02-27
Health check-in — 3 months, dose 2, dependent
Feeling: Good

Adult check-in
2022-05-22
Dose 3 — Pfizer-BioNTech
2022-05-29
Health check-in — day 7, dose 3, dependent
Feeling: Good · None

Adult check-in
2022-06-05
Survey response — day 14, dose 3, dependent
MedDRA: Malaise — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Covid sx

MedDRA releases: 2024-11 · check-in free text available
2022-06-05
Report sent to call center — day 14, dose 3, dependent
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · 1 call case(s)
2022-06-06
Call successful
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
2022-06-12
Health check-in — day 21, dose 3, dependent
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-11-05	Pfizer-BioNTech	No
2	2021-11-26	Pfizer-BioNTech	No
3	2022-05-22	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2021-12-03	Successful 2021-12-08	Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
2021-12-24	Successful 2021-12-27	Does not wish to fill out VAERS report
2022-06-05	Successful 2022-06-06	Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Free text

Release 10 — day 7, dose 2, dependent

2021-12-03

Systemic reaction (other): Eczema flare

Release 10 — day 28, dose 2, dependent

2021-12-24

Symptoms: Cold

Release 11 — day 14, dose 3, dependent

2022-06-05

Symptoms: Covid sx

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Malaise	·	·	✓
SD	Nasopharyngitis	·	·	✓
SRO	Eczema	·	·	✓
SRO	Pre-existing disease	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release